Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, USA.
Appl Environ Microbiol. 2011 Apr;77(7):2428-34. doi: 10.1128/AEM.02320-10. Epub 2011 Feb 4.
Streptococcus mutans UA159, whose genome is completely sequenced, produces two nonlantibiotic mutacins, mutacin IV (encoded by nlmAB) and mutacin V (encoded by nlmC). In this study, we investigated the contribution of nlmA and nlmB to mutacin IV activity and demonstrated by performing genetic studies as well as by using semipurified molecules that, in contrast to a previous report, both of these genes are required for optimum mutacin IV activity. We also showed that mutacin IV is active against multiple Streptococcus species. In contrast, mutacin V displayed a narrower inhibitory range than mutacin IV. Our results suggest that mutacin IV and mutacin V may act synergistically to inhibit various organisms.
变异链球菌 UA159 的基因组已完全测序,其产生两种非类菌素 mutacins,mutacin IV(由 nlmAB 编码)和 mutacin V(由 nlmC 编码)。在这项研究中,我们通过遗传研究以及使用半纯化分子研究了 nlmA 和 nlmB 对 mutacin IV 活性的贡献,并证明与之前的报道相反,这两个基因都是产生最佳 mutacin IV 活性所必需的。我们还表明 mutacin IV 对多种链球菌具有活性。相比之下,mutacin V 的抑制范围比 mutacin IV 窄。我们的结果表明 mutacin IV 和 mutacin V 可能协同作用以抑制各种生物体。